JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bobbin, R. P.
Right arrow Articles by Guth, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bobbin, R. P.
Right arrow Articles by Guth, P. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 1, 11-21, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


VENOCONSTRICTIVE ACTION OF BRADYKININ

Richard P. Bobbin 1 and Paul S. Guth 1

1 Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana

A preparation employing direct observation of the marginal ear vein of the rabbit in vivo was used to study the venoconstrictive action of bradykinin (BK). By means of this preparation several hypotheses concerning BK mechanism of action were examined. An indirect mechanism mediated by the venoconstrictor amines norepinephrine or histamine was ruled out by the use of the alpha adrenergic blocking drug phentolamine and an antihistamine, tripelennamine. That is, neither blocking drug reduced the BK-induced venoconstriction. 5-Hydroxytryptamine, tyramine and acetylcholine were studied for their possible venoconstrictive effects but were found to be inactive in this regard. Similarly, an indirect mechanism mediated by reflex reactions to BK-evoked pain or systemic hypotension was ruled out by studies in animals with denervated ears. That is, BK was equiactive in normal and denervated ears. It is therefore suggested that, until endogenous venoconstrictor substances not considered here are shown to be released by BK, it may be assumed that BK causes a direct action on venous smooth muscle.

Submitted on September 8, 1967
Accepted on November 9, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.